Guardant Health Inc.

NASDAQ: GH · Real-Time Price · USD
58.84
-1.52 (-2.52%)
At close: Aug 15, 2025, 3:59 PM
58.50
-0.58%
After-hours: Aug 15, 2025, 07:57 PM EDT

Guardant Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
828.85M 774M 739.02M 692.26M 643.81M 603.73M 563.95M 535.78M 510.16M 482.15M 449.54M 430.75M 408.13M 391.09M 373.65M 343.86M 323.65M 297.88M
Cost of Revenue
308.01M 299.23M 289.8M 131.07M 114.2M 95.62M 83.4M 211.66M 194.54M 177.42M 156.32M 142.63M 132.95M 126.15M 122.91M 117.9M 108.27M 100.78M
Gross Profit
520.84M 474.77M 449.22M 561.18M 529.61M 508.1M 480.55M 324.13M 315.62M 304.74M 293.21M 288.13M 275.18M 264.94M 250.74M 225.96M 215.38M 197.11M
Operating Income
-460.75M -454.95M -443.59M -515.14M -511.36M -530.35M -564.73M -513.33M -544.39M -555.1M -544.38M -496.47M -459.15M -426.48M -411M -403.96M -370.92M -327.9M
Interest Income
41.58M 47.94M 53.69M 55.93M 54.36M 47.17M 35.37M 23.63M 13.69M 8.35M 6.07M 4.57M 3.51M 3.16M 3.93M 5.18M 6.8M 8.4M
Pretax Income
-412.74M -415.38M -435.09M -512.38M -490.27M -460.05M -478.76M -430.51M -506.78M -663.49M -653.45M -586.42M -531.97M -400.47M -384.47M -404.95M -369.12M -321.34M
Net Income
-413.82M -416.55M -436.37M -512.41M -490.76M -460.9M -479.45M -432.34M -508.23M -664.89M -654.59M -605.57M -551.1M -419.24M -405.67M -408.5M -378.65M -335.71M
Selling & General & Admin
624.77M 577.25M 545.06M 505.21M 463.31M 453.54M 451.03M 453.55M 469.93M 474.65M 463.78M 444.35M 423.14M 401.95M 398.52M 399.44M 390.55M 356.66M
Research & Development
356.82M 352.47M 347.75M 344.07M 350.61M 357.87M 367.19M 383.92M 390.08M 385.18M 373.81M 340.25M 311.2M 289.47M 263.22M 230.48M 195.76M 168.35M
Other Expenses
n/a n/a n/a 227.05M 227.05M 227.05M 227.05M n/a n/a n/a -48K -48K -235K -478K -720K -720K -188K 55K
Operating Expenses
981.59M 929.72M 892.81M 1.08B 1.04B 1.04B 1.05B 837.46M 860.01M 859.83M 837.59M 784.6M 734.34M 691.42M 661.74M 629.92M 586.31M 525.01M
Interest Expense
1.1M 2.73M 2.58M 2.58M 2.58M 2.58M 2.58M 2.58M 2.58M 2.58M 2.58M 2.58M 2.58M 2.58M 2.58M 6.67M 6.03M 5.4M
Selling & Marketing Expenses
426.55M 388.83M 364.94M 339.3M 310.35M 299.53M 295.23M 297.52M 308.96M 311.52M 299.83M 278M 247.86M 221.97M 191.88M 163.57M 138.44M 115.74M
Cost & Expenses
1.29B 1.23B 1.18B 1.21B 1.16B 1.13B 1.13B 1.05B 1.05B 1.04B 993.92M 927.22M 867.28M 817.56M 784.65M 747.82M 694.57M 625.79M
Income Tax Expense
1.07M 1.17M 1.28M 27K 487K 850K 685K 1.83M 1.45M 1.4M 1.14M 548K 529K 166K 300K 552K 524K 475K
Shares Outstanding (Basic)
124.11M 123.87M 123.75M 123.05M 122.45M 121.71M 118.51M 117.74M 108.81M 102.66M 102.52M 102.29M 102.05M 101.85M 101.7M 101.42M 101.17M 100.95M
Shares Outstanding (Diluted)
124.11M 123.87M 123.75M 123.05M 122.45M 121.71M 118.51M 117.74M 108.81M 102.66M 102.52M 102.29M 102.05M 101.85M 101.7M 101.42M 101.17M 100.95M
EPS (Basic)
-3.35 -3.39 -3.56 -4.24 -4.09 -3.92 -4.28 -4.06 -4.91 -6.49 -6.4 -5.93 -5.41 -4.12 -4 -4.05 -3.77 -3.38
EPS (Diluted)
-3.35 -3.39 -3.56 -4.24 -4.09 -3.92 -4.28 -4.06 -4.91 -6.49 -6.4 -5.93 -5.41 -4.12 -4 -4.05 -3.77 -3.38
EBITDA
-413.13M -397.86M -390.04M -466.92M -444.38M -414.22M -433.31M -385.75M -463.25M -621.81M -614.91M -551.96M -501.82M -373.51M -359.69M -377.57M -343.52M -296.28M
EBIT
-411.26M -414.23M -432.51M -509.8M -487.69M -457.47M -476.19M -427.94M -504.2M -660.91M -650.87M -583.84M -529.39M -397.9M -381.89M -398.28M -363.09M -315.94M
Depreciation & Amortization
5.67M 16.37M 42.46M 42.88M 43.32M 43.25M 42.88M 42.18M 40.95M 39.11M 35.96M 31.88M 27.58M 24.39M 22.2M 20.71M 19.57M 19.66M